BLFS logo

BioLife Solutions, Inc. (BLFS)

Profile

Full Name

BioLife Solutions, Inc.

Ticker

NASDAQ: BLFS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

November 22, 1989

Indexes

Not included

Website

http://www.biolifesolutions.com

Employees

159

Key Details

Price

$22.45(+4.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$82.25M(+8.44% YoY)

Annual EPS

-$0.44(+71.61% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $22.45
    BLFS price is $22.45

    30-Day Relative Volume

    0.97
    BLFS 30-day relative volume is 0.97

    Price Performance

    Price Most recent change

    +4.86%
    BLFS price was up +4.86% on Jul 23, 2025

    Price YTD change

    -13.52%
    BLFS price is down -13.52% since January 1st

    Price 1-year change

    +0.45%
    BLFS price is up +0.45% year-on-year

    Price 3-year change

    +26.55%
    BLFS price is up +26.55% over the past 3 years

    Price Range

    Price All-time high

    $1382.50
    BLFS price is currently -98.38% below its historical high of $1382.50

    Price 3-year low

    $8.92
    BLFS price is currently +151.68% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.07B
    BLFS market capitalization is $1.07 billion

    Market cap 3-year change

    +42.31%
    BLFS market capitalization is up +42.31% over the past 3 years

    Market cap All-time high

    $2.49B
    BLFS market capitalization is currently -56.95% below its historical high of $2.49 billion

    Market cap sector rank

    75.08%
    BLFS market capitalization is higher than 75.08% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.75%
    BLFS shares outstanding is up +3.75% year-on-year

    Shares Outstanding 3-Year Change

    +12.46%
    BLFS shares outstanding is up +12.46% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.37
    BLFS beta is 1.37

    200-day SMA

    $24.35
    BLFS price is currently -7.82% below its 200-day simple moving average

    50-day SMA

    $22.13
    BLFS price is currently +1.46% above its 50-day simple moving average

    RSI

    54.55
    BLFS 14-day relative strength index is 54.55

    Volume

    0.97
    BLFS 30-day relative volume is 0.97

    ATR

    $1.03
    BLFS average true range is $1.03

    10-day Historical Volatility

    50.81%
    BLFS 10-day historical volatility is 50.81%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $82.25M
    BLFS annual revenue is $82.25 million

    Revenue Analysts estimate

    $97.75M
    BLFS annual revenue is currently -15.85% lower than the consensus analysts' forecast

    Revenue 1-year change

    +8.44%
    BLFS annual revenue is up +8.44% year-on-year

    Revenue Sector rank

    54.17%
    BLFS annual revenue is higher than 54.17% of companies in Healthcare sector

    EPS

    EPS

    -$0.44
    BLFS annual earnings per share is -$0.44

    EPS Analysts estimate

    $0.02
    BLFS annual earnings per share is currently -2300.00% lower than the consensus analysts' forecast

    EPS 1-year change

    +71.61%
    BLFS annual earnings per share is up +71.61% year-on-year

    EPS Sector rank

    69.1%
    BLFS annual earnings per share is higher than 69.1% of companies in Healthcare sector

    Profit

    Gross profit

    $53.67M
    BLFS annual gross profit is $53.67 million

    Gross margin

    65.25%
    BLFS annual gross profit margin is 65.25%

    Operating profit

    -$7.13M
    BLFS annual operating income is -$7.13 million

    Operating margin

    -8.67%
    BLFS annual operating profit margin is -8.67%

    Net income

    -$20.18M
    BLFS annual net profit is -$20.18 million

    Net margin

    -24.54%
    BLFS annual net profit margin is -24.54%

    Expenses

    Total expenses

    $89.38M
    BLFS annual total expenses is $89.38 million

    Operating expenses

    $60.80M
    BLFS annual total operating expenses is $60.80 million

    Cost of goods sold

    $28.58M
    BLFS annual cost of goods sold is $28.58 million

    Selling, general & administrative expenses

    $50.15M
    BLFS annual SGA is $50.15 million

    Depreciation and amortization

    $8.66M
    BLFS annual depreciation & amortization is $8.66 million

    Interest expense

    -
    BLFS annual interest expense value is unknown

    Income tax

    -$38.00K
    BLFS annual income tax is -$38.00 thousand

    EBIT & EBITDA

    EBIT

    -$7.13M
    BLFS annual earnings before interest & taxes is -$7.13 million

    EBITDA

    $1.53M
    BLFS annual EBITDA is $1.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $399.49M
    BLFS annual total assets is $399.49 million

    Non current assets

    $250.73M
    BLFS annual long term assets is $250.73 million

    Current assets

    $148.76M
    BLFS annual total current assets is $148.76 million

    Cash and cash equivalents

    $95.39M
    BLFS annual cash & cash equivalents is $95.39 million

    Accounts receivable

    $9.17M
    BLFS annual accounts receivable is $9.17 million

    Inventory

    $29.01M
    BLFS annual inventory is $29.01 million

    Liabilities

    Total liabilities

    $50.58M
    BLFS annual total liabilities is $50.58 million

    Long term liabilities

    $17.84M
    BLFS annual total long term liabilities is $17.84 million

    Current liabilities

    $32.73M
    BLFS annual total current liabilities is $32.73 million

    Accounts payable

    $3.57M
    BLFS annual accounts payable is $3.57 million

    Debt

    Total debt

    $30.17M
    BLFS annual total debt is $30.17 million

    Total debt 1-year change

    -10.8%
    BLFS annual total debt is down -10.8% year-on-year

    Long term debt

    $17.72M
    BLFS annual long term debt is $17.72 million

    Short term debt

    $12.45M
    BLFS annual short term debt is $12.45 million

    Equity & Capital

    Shareholders equity

    $348.91M
    BLFS annual stockholders equity is $348.91 million

    Book value

    $348.91M
    BLFS annual book value is $348.91 million

    Retained earnings

    -$335.10M
    BLFS annual retained earnings is -$335.10 million

    Working capital

    $116.03M
    BLFS annual working capital is $116.03 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $8.43M
    BLFS annual cash flow from operations is $8.43 million

    Cash from operations 1-year change

    +167.46%
    BLFS annual cash flow from operations is up +167.46% year-on-year

    Cash from investing

    $58.30M
    BLFS annual cash flow from investing activities is $58.30 million

    Cash from investing 1-year change

    +226.85%
    BLFS annual cash flow from investing activities is up +226.85% year-on-year

    Cash from financing

    -$6.78M
    BLFS annual cash flow from financing activities is -$6.78 million

    Cash from financing 1-year change

    -164.04%
    BLFS annual cash flow from financing activities is down -164.04% year-on-year

    CAPEX

    CAPEX

    $3.53M
    BLFS annual capital expenditures is $3.53 million

    CAPEX 1-year change

    -44.73%
    BLFS annual capital expenditures is down -44.73% year-on-year

    Free Cash Flow

    Free cash flow

    $4.90M
    BLFS annual free cash flow is $4.90 million

    Free cash flow 1-year change

    +125.98%
    BLFS annual free cash flow is up +125.98% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    65.25%
    BLFS annual gross profit margin is 65.25%

    Operating margin

    -8.67%
    BLFS annual operating profit margin is -8.67%

    Net margin

    -24.54%
    BLFS annual net profit margin is -24.54%

    ROA & ROE

    ROA

    -4.97%
    BLFS annual return on assets is -4.97%

    ROE

    -5.88%
    BLFS annual return on equity is -5.88%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BLFS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BLFS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.05
    BLFS price to book ratio is 3.05

    PB ratio Sector rank

    66.34%
    BLFS price to book ratio is higher than 66.34% of companies in Healthcare sector

    PS Ratio

    PS ratio

    13.52
    BLFS price to sales ratio is 13.52

    PS ratio Sector rank

    80.64%
    BLFS price to sales ratio is higher than 80.64% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.03B
    BLFS enterprise value is $1.03 billion

    Enterprise value Sector rank

    74.23%
    BLFS enterprise value is higher than 74.23% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    309.27
    BLFS EV/EBITDA is 309.27

    EV/EBITDA Sector rank

    99.74%
    BLFS EV/EBITDA is higher than 99.74% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.54
    BLFS annual current ratio is 4.54

    Quick ratio

    3.66
    BLFS annual quick ratio is 3.66

    Leverage

    Debt to equity

    0.05
    BLFS annual debt to equity ratio is 0.05

    Interest coverage ratio

    -
    BLFS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    BLFS piotroski f-score is 5

    Altman Z-Score

    12.06
    BLFS altman z-score is 12.06

    Analyst ratings

    Recent major analysts updates

    May 13, 25 HC Wainwright & Co.
    Buy
    Mar 6, 25 HC Wainwright & Co.
    Buy
    Jan 8, 25 Northland Capital Markets
    Outperform
    Dec 19, 24 Benchmark
    Buy
    Dec 13, 24 Keybanc
    Overweight
    Nov 18, 24 HC Wainwright & Co.
    Buy
    Nov 13, 24 TD Cowen
    Buy
    Nov 13, 24 Craig-Hallum
    Buy
    Sep 30, 24 HC Wainwright & Co.
    Buy
    Aug 12, 24 Craig-Hallum
    Buy

    Institutional Ownership

    Screeners with BLFS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for BioLife Solutions, Inc.?
    • Does BioLife Solutions, Inc. pay dividends?
    • What sector is BioLife Solutions, Inc. in?
    • What industry is BioLife Solutions, Inc. in?
    • What country is BioLife Solutions, Inc. based in?
    • When did BioLife Solutions, Inc. go public?
    • Is BioLife Solutions, Inc. in the S&P 500?
    • Is BioLife Solutions, Inc. in the NASDAQ 100?
    • Is BioLife Solutions, Inc. in the Dow Jones?
    • When was BioLife Solutions, Inc.'s last earnings report?
    • When does BioLife Solutions, Inc. report earnings?

    What is the ticker symbol for BioLife Solutions, Inc.?

    The ticker symbol for BioLife Solutions, Inc. is NASDAQ:BLFS

    Does BioLife Solutions, Inc. pay dividends?

    No, BioLife Solutions, Inc. does not pay dividends

    What sector is BioLife Solutions, Inc. in?

    BioLife Solutions, Inc. is in the Healthcare sector

    What industry is BioLife Solutions, Inc. in?

    BioLife Solutions, Inc. is in the Medical Instruments & Supplies industry

    What country is BioLife Solutions, Inc. based in?

    BioLife Solutions, Inc. is headquartered in United States

    When did BioLife Solutions, Inc. go public?

    BioLife Solutions, Inc.'s initial public offering (IPO) was on November 22, 1989

    Is BioLife Solutions, Inc. in the S&P 500?

    No, BioLife Solutions, Inc. is not included in the S&P 500 index

    Is BioLife Solutions, Inc. in the NASDAQ 100?

    No, BioLife Solutions, Inc. is not included in the NASDAQ 100 index

    Is BioLife Solutions, Inc. in the Dow Jones?

    No, BioLife Solutions, Inc. is not included in the Dow Jones index

    When was BioLife Solutions, Inc.'s last earnings report?

    BioLife Solutions, Inc.'s most recent earnings report was on May 8, 2025

    When does BioLife Solutions, Inc. report earnings?

    The next expected earnings date for BioLife Solutions, Inc. is August 8, 2025
    On this page